{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:43:38Z","timestamp":1782139418392,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004386","name":"Universiti Malaya","doi-asserted-by":"publisher","award":["IPPP (PG001-2012B)"],"award-info":[{"award-number":["IPPP (PG001-2012B)"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12906-017-1610-x","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T07:45:41Z","timestamp":1486367141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antidiabetic effects of Brucea javanica seeds in type 2 diabetic rats"],"prefix":"10.1186","volume":"17","author":[{"given":"Abdulwali","family":"Ablat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Farouq","family":"Halabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamaludin","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hafiz Husna","family":"Hasnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazrina","family":"Hazni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ser-huy","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil A.","family":"Shilpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulqarnain","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalijah","family":"Awang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"issue":"2","key":"1610_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137\u201349.","journal-title":"Diabetes Res Clin Pract"},{"issue":"Supplement 1","key":"1610_CR2","first-page":"S4","volume":"38","author":"ADA","year":"2015","unstructured":"ADA. Standards of Medical Care in Diabetes\u20142015: Summary of Revisions. Diabetes Care. 2015;38(Supplement 1):S4.","journal-title":"Diabetes Care"},{"issue":"1","key":"1610_CR3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.diabres.2014.09.047","volume":"107","author":"UM Mogensen","year":"2015","unstructured":"Mogensen UM, et al. Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality\u2014A retrospective nationwide study. Diabetes Res Clin Pract. 2015;107(1):104\u201312.","journal-title":"Diabetes Res Clin Pract"},{"key":"1610_CR4","doi-asserted-by":"crossref","unstructured":"Aso Y, et al. Sitagliptin, a DPP-4 inhibitor, alters the subsets of circulating CD4+ T cells in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 2015;110(3):250\u20136.","DOI":"10.1016\/j.diabres.2015.10.012"},{"issue":"5","key":"1610_CR5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.metabol.2012.10.015","volume":"62","author":"Y Hamada","year":"2013","unstructured":"Hamada Y, et al. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice. Metabolism. 2013;62(5):734\u201342.","journal-title":"Metabolism"},{"key":"1610_CR6","doi-asserted-by":"crossref","unstructured":"Bonner C, et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med. 2015;21:512\u20137.","DOI":"10.1038\/nm.3828"},{"issue":"6","key":"1610_CR7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.metabol.2013.12.014","volume":"63","author":"C Imai","year":"2014","unstructured":"Imai C, et al. Cotreatment with the \u03b1-glucosidase inhibitor miglitol and DPP-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of CVD risk factors in type 2 diabetic Japanese patients. Metabolism. 2014;63(6):746\u201353.","journal-title":"Metabolism"},{"issue":"7","key":"1610_CR8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0149-2918(03)80195-9","volume":"25","author":"S Braunstein","year":"2003","unstructured":"Braunstein S. New developments in type 2 diabetes mellitus: Combination therapy with a thiazolidinedione. Clin Ther. 2003;25(7):1895\u2013917.","journal-title":"Clin Ther"},{"issue":"10","key":"1610_CR9","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.clinthera.2012.09.007","volume":"34","author":"P Norwood","year":"2012","unstructured":"Norwood P, et al. Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years. Clin Ther. 2012;34(10):2082\u201390.","journal-title":"Clin Ther"},{"key":"1610_CR10","doi-asserted-by":"crossref","first-page":"65R","DOI":"10.1203\/01.pdr.0000206857.38581.49","volume":"59","author":"JJ Meier","year":"2006","unstructured":"Meier JJ, Bhushan A, Butler PC. The potential for stem cell therapy in diabetes. Pediatr Res. 2006;59:65R\u201373R.","journal-title":"Pediatr Res"},{"key":"1610_CR11","doi-asserted-by":"crossref","first-page":"859048","DOI":"10.1155\/2015\/859048","volume":"2015","author":"N Auberval","year":"2015","unstructured":"Auberval N, et al. Oxidative stress type influences the properties of antioxidants containing polyphenols in RINm5F beta cells. Evid Based Complement Alternat Med. 2015;2015:859048.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"1610_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12906-015-0760-y","volume":"15","author":"OR Oyenihi","year":"2015","unstructured":"Oyenihi OR, Brooks NL, Oguntibeju OO. Effects of kolaviron on hepatic oxidative stress in streptozotocin induced diabetes. BMC Complement Altern Med. 2015;15(1):236.","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"1610_CR13","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.tiv.2015.08.006","volume":"29","author":"ML Porto","year":"2015","unstructured":"Porto ML, et al. Increased oxidative stress and apoptosis in peripheral blood mononuclear cells of fructose-fed rats. Toxicol in Vitro. 2015;29(8):1977\u201381.","journal-title":"Toxicol in Vitro"},{"issue":"07","key":"1610_CR14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1055\/s-0034-1368349","volume":"80","author":"A Zahari","year":"2014","unstructured":"Zahari A, et al. Antiplasmodial and Antioxidant Isoquinoline Alkaloids from Dehaasia longipedicellata. Planta Med. 2014;80(07):599\u2013603.","journal-title":"Planta Med"},{"issue":"5","key":"1610_CR15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","volume":"24","author":"A Ceriello","year":"2004","unstructured":"Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24(5):816\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1610_CR16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.27.3.813","volume":"27","author":"JC Pickup","year":"2004","unstructured":"Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813\u201323.","journal-title":"Diabetes Care"},{"issue":"1","key":"1610_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cbdv.200700409","volume":"6","author":"JH Liu","year":"2009","unstructured":"Liu JH, et al. Chemical constituents of plants from the genus Brucea. Chem Biodivers. 2009;6(1):57\u201370.","journal-title":"Chem Biodivers"},{"issue":"3","key":"1610_CR18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjc.6605487","volume":"102","author":"S Lau","year":"2010","unstructured":"Lau S, Lin Z, Leung P. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-\u03baB signalling pathways in human pancreatic adenocarcinoma cells. Br J Cancer. 2010;102(3):583\u201393.","journal-title":"Br J Cancer"},{"issue":"3","key":"1610_CR19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jep.2009.04.058","volume":"124","author":"A NoorShahida","year":"2009","unstructured":"NoorShahida A, Wong TW, Choo CY. Hypoglycemic effect of quassinoids from Brucea javanica (L.) Merr (Simaroubaceae) seeds. J Ethnopharmacol. 2009;124(3):586\u201391.","journal-title":"J Ethnopharmacol"},{"key":"1610_CR20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2014\/786130","volume":"2014","author":"A Ablat","year":"2014","unstructured":"Ablat A, et al. Evaluation of Antidiabetic and Antioxidant Properties of Brucea javanica Seed. Sci World J. 2014;2014:8.","journal-title":"Sci World J"},{"issue":"3","key":"1610_CR21","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.foodchem.2013.04.123","volume":"141","author":"S Lordan","year":"2013","unstructured":"Lordan S, et al. The \u03b1-amylase and \u03b1-glucosidase inhibitory effects of Irish seaweed extracts. Food Chem. 2013;141(3):2170\u20136.","journal-title":"Food Chem"},{"key":"1610_CR22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jff.2014.04.016","volume":"9","author":"E Cuevas-Ju\u00e1rez","year":"2014","unstructured":"Cuevas-Ju\u00e1rez E, et al. Antioxidant and \u03b1-glucosidase inhibitory properties of soluble melanins from the fruits of Vitex mollis Kunth, Randia echinocarpa Sess\u00e9 et Moci\u00f1o and Crescentia alata Kunth. J Funct Foods. 2014;9:78\u201388.","journal-title":"J Funct Foods"},{"issue":"1","key":"1610_CR23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jep.2012.08.014","volume":"144","author":"A Arya","year":"2012","unstructured":"Arya A, et al. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, \u03b2-TC6 and its alleviating role in type 2 diabetic rats. J Ethnopharmacol. 2012;144(1):22\u201332.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1610_CR24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12906-015-0806-1","volume":"15","author":"C-W Chang","year":"2015","unstructured":"Chang C-W, et al. Effects of combined extract of cocoa, coffee, green tea and garcinia on lipid profiles, glycaemic markers and inflammatory responses in hamsters. BMC Complement Altern Med. 2015;15(1):269.","journal-title":"BMC Complement Altern Med"},{"issue":"4, Supplement 1","key":"1610_CR25","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0002-9149(98)00033-2","volume":"81","author":"M Grundy","year":"1998","unstructured":"Grundy M, P.S.M. Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome. Am J Cardiol. 1998;81(4, Supplement 1):18B\u201325B.","journal-title":"Am J Cardiol"},{"key":"1610_CR26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199000169-00002","volume":"16","author":"SL Abbate","year":"1990","unstructured":"Abbate SL, Brunzell JD. Pathophysiology of hyperlipidemia in diabetes mellitus. J Cardiovasc Pharmacol. 1990;16:S1\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"1610_CR27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI10934","volume":"107","author":"L Rui","year":"2001","unstructured":"Rui L, et al. Insulin\/IGF-1 and TNF-\u03b1 stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Investig. 2001;107(2):181.","journal-title":"J Clin Investig"},{"issue":"1","key":"1610_CR28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10715762.2013.847528","volume":"48","author":"A Gratas-Delamarche","year":"2014","unstructured":"Gratas-Delamarche A, et al. Physical inactivity, insulin resistance, and the oxidative-inflammatory loop. Free Radic Res. 2014;48(1):93\u2013108.","journal-title":"Free Radic Res"},{"issue":"1\u20132","key":"1610_CR29","first-page":"46","volume":"381","author":"ILMH Aye","year":"2013","unstructured":"Aye ILMH, Jansson T, Powell TL. Interleukin-1\u03b2 inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts. Mol Cell Endocrinol. 2013;381(1\u20132):46\u201355.","journal-title":"Mol Cell Endocrinol"},{"key":"1610_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.freeradbiomed.2013.10.807","volume":"67","author":"E Hatem","year":"2014","unstructured":"Hatem E, et al. Glutathione is essential to preserve nuclear function and cell survival under oxidative stress. Free Radic Biol Med. 2014;67:103\u201314.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1610_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","volume":"52","author":"JL Evans","year":"2003","unstructured":"Evans JL, et al. Are Oxidative Stress\u2009\u2212\u2009Activated Signaling Pathways Mediators of Insulin Resistance and \u03b2-Cell Dysfunction? Diabetes. 2003;52(1):1\u20138.","journal-title":"Diabetes"},{"issue":"6","key":"1610_CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/1357-2725(95)00029-O","volume":"27","author":"D Grekinis","year":"1995","unstructured":"Grekinis D, Reimann EM, Schlender KK. Phosphorylation and inactivation of rat heart glycogen synthase by cAMP-dependent and cAMP-independent protein kinases. Int J Biochem Cell Biol. 1995;27(6):565\u201373.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1610_CR33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.diabet.2013.03.002","volume":"39","author":"F Rajas","year":"2013","unstructured":"Rajas F, Labrune P, Mithieux G. Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders. Diabetes Metab. 2013;39(5):377\u201387.","journal-title":"Diabetes Metab"},{"issue":"7","key":"1610_CR34","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1021\/jf0489926","volume":"53","author":"GJ McDougall","year":"2005","unstructured":"McDougall GJ, et al. Different Polyphenolic Components of Soft Fruits Inhibit \u03b1-Amylase and \u03b1-Glucosidase. J Agric Food Chem. 2005;53(7):2760\u20136.","journal-title":"J Agric Food Chem"},{"key":"1610_CR35","doi-asserted-by":"crossref","unstructured":"Agius, L., Role of glycogen phosphorylase in liver glycogen metabolism. Mol Asp Med, 2015.","DOI":"10.1016\/j.mam.2015.09.002"},{"key":"1610_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijbiomac.2013.12.007","volume":"64","author":"J Yan","year":"2014","unstructured":"Yan J, et al. \u03b1-Glucosidase inhibition by luteolin: Kinetics, interaction and molecular docking. Int J Biol Macromol. 2014;64:213\u201323.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1610_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-8741(98)00061-0","volume":"62","author":"P Peungvicha","year":"1998","unstructured":"Peungvicha P, et al. 4-Hydroxybenzoic acid: a hypoglycemic constituent of aqueous extract of Pandanus odorus root. J Ethnopharmacol. 1998;62(1):79\u201384.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1610_CR38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10787-011-0086-4","volume":"19","author":"AB Lende","year":"2011","unstructured":"Lende AB, et al. Anti-inflammatory and analgesic activity of protocatechuic acid in rats and mice. Inflammopharmacology. 2011;19(5):255\u201363.","journal-title":"Inflammopharmacology"},{"issue":"1\u20132","key":"1610_CR39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cbi.2010.11.005","volume":"189","author":"RCR Latha","year":"2011","unstructured":"Latha RCR, Daisy P. Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats. Chem Biol Interact. 2011;189(1\u20132):112\u20138.","journal-title":"Chem Biol Interact"},{"key":"1610_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2014.10.044","volume":"745","author":"GR Gandhi","year":"2014","unstructured":"Gandhi GR, et al. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPAR\u03b3 in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K\/p-Akt signaling pathway. Eur J Pharmacol. 2014;745:201\u201316.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1610_CR41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejphar.2010.08.059","volume":"650","author":"VR Punithavathi","year":"2011","unstructured":"Punithavathi VR, et al. Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol. 2011;650(1):465\u201371.","journal-title":"Eur J Pharmacol"},{"key":"1610_CR42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cbi.2015.08.026","volume":"240","author":"A Ahad","year":"2015","unstructured":"Ahad A, et al. Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells. Chem Biol Interact. 2015;240:292\u2013303.","journal-title":"Chem Biol Interact"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-017-1610-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T05:26:12Z","timestamp":1568784372000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-017-1610-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1610"],"URL":"https:\/\/doi.org\/10.1186\/s12906-017-1610-x","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]},"article-number":"94"}}